To be able to develop new treatments, researchers and clinicians need to understand the biology for each different type of ovarian cancer. Since low grade serous is less common, less research has been carried out on this type of ovarian cancer. Hear from Professor Charlie Gourley (Clinical Director of the Cancer Research UK Scotland Centre) about the valuable information his recent research project has contributed, and how the findings can hopefully be built on to develop new treatments. Dr Emma Dennett (Target Ovarian Cancer's Research Manager) also shares more about Target Ovarian Cancer’s research programme.
You can catch up on the latest advice from the experts by watching our full collection of information and wellbeing events back at a time that suits you, in the Ovarian Cancer Community, our kind, supportive group for everyone affected by ovarian cancer, including friends and family. Join today to find support, strength and community from people who understand what you’re going through: bit.ly/2GJQpg2
2 окт 2023
